Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Bromfenac sodiu

InhA, Func 120638-55-3
Produktnummer ABIN3220275
  • Applikation
    Inhibition Assay (InhA), Functional Studies (Func)
    Verwendungszweck
    Bromfenac Sodium is the sodium salt form of bromfenac, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory activities. Upon ophthalmic administration, bromfenac binds to and inhibits the activity of cyclooxygenase II (COX II), an enzyme which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins (PG). By inhibiting PG formation, bromfenac is able to inhibit PG-induced inflammation, thereby preventing vasodilation, leukocytosis, disruption of the blood-aqueous humor barrier, an increase in vascular permeability and an increase in intraocular pressure (IOP).
    Produktmerkmale
    Target: COX inhibitor
    Receptor: COX-2
    Aufreinigung
    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
    Reinheit
    97 % +
    Formel
    C15H11BrNNaO3
    Löslichkeit
    10 mM in DMSO
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Solid
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
    Haltbarkeit
    24 months
  • Hintergrund
    Neuroscience
    Molekulargewicht
    356.15 g/mol
    CAS-Nummer
    120638-55-3
Sie sind hier:
Kundenservice